Atlas Trials

Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia

Clinical trial NCT01890694 · TERMINATED

Trial details

NCT number
NCT01890694
Sponsor
NYU Langone Health
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Hyponatremia
Start date
2012-03-01
Primary completion
2015-03-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.